Form 4: BioAtla's Chief Medical Officer Reports Share Transaction
SEC Form 4 Filing
Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.
Summary
- On June 30, 2024, Eric Sievers, the Chief Medical Officer of BioAtla, Inc., had 572 shares withheld by the issuer to satisfy income tax obligations.
- The shares were withheld at a price of $1.37 per share.
- Following the transaction, Sievers beneficially owns 208,706 shares of BioAtla, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a small number of shares withheld for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of transaction (share withholding for tax obligations). |
| 07/01/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.